Search Results - "Beris, P."

Refine Results
  1. 1

    Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines by Goodnough, L.T., Maniatis, A, Earnshaw, P, Benoni, G, Beris, P, Bisbe, E, Fergusson, D.A., Gombotz, H, Habler, O, Monk, T.G., Ozier, Y, Slappendel, R, Szpalski, M

    Published in British journal of anaesthesia : BJA (01-01-2011)
    “…Previously undiagnosed anaemia is common in elective orthopaedic surgical patients and is associated with increased likelihood of blood transfusion and…”
    Get full text
    Journal Article
  2. 2

    Perioperative anaemia management: consensus statement on the role of intravenous iron by Beris, P., Muñoz, M., García-Erce, J.A., Thomas, D., Maniatis, A., Van der Linden, P.

    Published in British journal of anaesthesia : BJA (01-05-2008)
    “…A multidisciplinary panel of physicians was convened by Network for Advancement of Transfusion Alternatives to review the evidence on the efficacy and safety…”
    Get full text
    Journal Article
  3. 3

    Zinc-induced copper deficiency in Wilson disease by Horvath, J, Beris, P, Giostra, E, Martin, P-Y, Burkhard, P R

    “…Neurological manifestations of copper deficiency typically involve a myelopathy resembling subacute combined degeneration, yet optic and peripheral…”
    Get full text
    Journal Article
  4. 4

    Atypical presentation of acute myeloid leukemia: cardiac myeloid sarcoma by Rigamonti, Fabio, Beris, P., Sanchez-Pareja, A., Meyer, P., Ashrafpoor, G., Zaza, S., Passweg, J., Chalandon, Y.

    Published in International journal of hematology (01-06-2009)
    “…We present the case of a 52-year-old man with a 2-month history of dyspnea, bilateral pleural effusion and cardiomegaly of rapid onset. A cardiac ultrasound…”
    Get full text
    Journal Article
  5. 5

    Lentiviral PU.1 overexpression restores differentiation in myeloid leukemic blasts by DURUAL, S, RIDEAU, A, RUAULT-JUNGBLUT, S, COSSALI, D, BERIS, P, PIGUET, V, MATTHES, T

    Published in Leukemia (01-05-2007)
    “…PU.1, a transcription factor of the ETS family, plays a pivotal role in normal hematopoiesis, and particularly in myeloid differentiation. Altered PU.1…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Iron overload in patients with sideroblastic anaemia is not related to the presence of the haemochromatosis Cys282Tyr and His63Asp mutations by Beris, P., Samii, K., Darbellay, R., Zoumbos, N., Tsoplou, P., Kourakli, A., Preud'Homme, C., Fenaux, P.

    Published in British journal of haematology (01-01-1999)
    “…Forty Caucasian patients with primary acquired sideroblastic anaemia (SA), were investigated for the presence of the Cys282Tyr and/or His63Asp mutation as…”
    Get full text
    Journal Article
  8. 8

    Epoetin alfa: new directions in orthopedic surgery by Beris, P

    Published in Seminars in hematology (01-04-1996)
    “…The introduction of autologous blood (AB) donation programs has led to a decrease in the number of orthopedic surgery patients exposed to allogeneic blood,…”
    Get more information
    Journal Article
  9. 9

    Optimized lentiviral transduction of erythroid precursors from healthy adults and patients with myelodysplastic syndromes by MATTHES, T. W, KINDLER, V, LEUBA, F, FRENCH, L. E, CHAPUIS, B, BERIS, P, PIGUET, V

    Published in Leukemia (01-07-2002)
    “…Lentivectors, derived from human immunodeficiency virus-1 (HIV-1), represent a novel investigational and therapeutic tool for targeting hematopoietic…”
    Get full text
    Journal Article
  10. 10

    Recombinant human erythropoietin as adjuvant treatment for autologous blood donation in elective surgery with large blood needs (> or=5 units): a randomized study by De Pree, Christian, Mermillod, Bernadette, Hoffmeyer, Pierre, Beris, Photis

    Published in Transfusion (Philadelphia, Pa.) (01-07-1997)
    “…BACKGROUND: Autologous blood transfusion presents no infectious or immunologic side effects. The aim of this randomized study was to determine the impact of…”
    Get full text
    Journal Article
  11. 11

    Adoptive immunotherapy for recurrent CML after BMT by Helg, C, Roux, E, Beris, P, Cabrol, C, Wacker, P, Darbellay, R, Wyss, M, Jeannet, M, Chapuis, B, Roosnek, E

    Published in Bone marrow transplantation (Basingstoke) (01-08-1993)
    “…Three patients with CML who relapsed after transplantation with T-depleted BM from their HLA-identical siblings were treated with transfusions of donor…”
    Get more information
    Journal Article
  12. 12

    Myelodysplasia in a patient with pre-existing paroxysmal nocturnal haemoglobinuria: a clonal disease originating from within a clonal disease by Longo, L, Bessler, M, Beris, P, Swirsky, D, Luzzatto, L

    Published in British journal of haematology (01-06-1994)
    “…Paroxysmal nocturnal haemoglobinuria (PNH) is an acquired haemolytic anaemia, clonal in nature, due to somatic mutation. PNH may evolve to aplastic anaemia;…”
    Get more information
    Journal Article
  13. 13

    Epoetin alfa as an adjuvant to autologous blood donation by Beris, P

    Published in Seminars in hematology (01-04-1996)
    “…The development of anemia is one factor that can limit the donation of sufficient autologous blood (AB) to meet a patient's expected blood requirements…”
    Get more information
    Journal Article
  14. 14

    Spurious Extreme Reticulocytosis with an Automated Reticulocyte Analyzer by Laurencet, France M, Martinez, Thelmo, Beris, Photis

    Published in The New England journal of medicine (25-12-1997)
    “…To the Editor: Automated reticulocyte analysis is based on flow-cytometric techniques and the Sysmex R series of instruments for quantification of erythrocyte…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Thalidomide in patients with advanced multiple myeloma by Yakoub-Agha, I, Moreau, P, Leyvraz, S, Berthou, C, Payen, C, Dumontet, C, Grosbois, B, Beris, P, Duguet, C, Attal, M, Harousseau, J L, Facon, T

    “…Recently, a report has suggested the efficacy and safety of thalidomide in refractory multiple myeloma. In an attempt to assess the efficacy and tolerance of…”
    Get more information
    Journal Article
  18. 18
  19. 19
  20. 20

    Etoposide and secondary haematological malignancies: coincidence or causality? by Zulian, G B, Jotterand Bellomo, M, Cabrol, C, Beris, P, Mermillod, B, Alberto, P

    Published in Annals of oncology (01-08-1993)
    “…Secondary haematological malignancies (SHM) induced by alkylating agents show cytogenetic abnormalities involving mainly chromosomes 5 and 7. Etoposide and…”
    Get more information
    Journal Article